Financials
- Market Capitalization 2.17 B
- Employee 128
- Founded 2012
- CEO N/A
- Website www.auriniapharma.com
- Headquarter Alberta, Canada
- FIGI BBG000BCRJM5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
7.71
Relación precio/flujo de caja
7.82
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1924 | MESO Mesoblast Limited - American Depositary Shares | 17.44 USD | -4.07% | +3.81% | +21.79% | +33.64% | 2.26 B USD | ||
| 1941 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 20.86 USD | -3.38% | +12.39% | +34.23% | +15.57% | 2.20 B USD | ||
| 1961 | URGN UroGen Pharma Ltd. - Ordinary Shares | 43.62 USD | -4.13% | -6.76% | +8.18% | +129.58% | 2.13 B USD | ||
| 1972 | VCEL Vericel Corporation - Common Stock | 40.95 USD | -0.56% | -4.05% | -16.26% | +12.65% | 2.10 B USD |